Immunic Inc (NASDAQ:IMUX) has a beta value of 1.49 and has seen 14.08 million shares traded in the last trading session. The IMUX stock price is -197.18% off its 52-week high price of $2.11 and 21.13% above the 52-week low of $0.56. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.36 million shares traded. The 3-month trading volume is 1.44 million shares.
The consensus among analysts is that Immunic Inc (IMUX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
Immunic Inc (NASDAQ:IMUX) trade information
Over the past 30 days, the shares of Immunic Inc (NASDAQ:IMUX) have changed -23.10%. Short interest in the company has seen 4.25 million shares shorted with days to cover at 2.35.
Wall Street analysts have a consensus price target for the stock at $5, which means that the shares’ value could jump 85.8% from current levels. The projected low price target is $5.0 while the price target rests at a high of $5.0. In that case, then, we find that the current price level is -604.23% off the targeted high while a plunge would see the stock gain -604.23% from current levels.
Immunic Inc (IMUX) estimates and forecasts
The company’s shares have lost -31.26% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.01% over the past 5 years.
IMUX Dividends
Immunic Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Immunic Inc (NASDAQ:IMUX)’s Major holders
Insiders own 1.35% of the company shares, while shares held by institutions stand at 44.81% with a share float percentage of 45.43%. Investors are also buoyed by the number of investors in a company, with Immunic Inc having a total of 79.0 institutions that hold shares in the company. The top two institutional holders are BVF INC/IL with over 8.9 million shares worth more than $9.88 million. As of 2024-06-30, BVF INC/IL held 9.15% of shares outstanding.
The other major institutional holder is AVIDITY PARTNERS MANAGEMENT LP, with the holding of over 8.9 million shares as of 2024-06-30. The firm’s total holdings are worth over $9.88 million and represent 9.15% of shares outstanding.
